Cross-Sector entity
Allison Transmission is most often covered alongside Alcon, which appears in 3 of these 3 stories. Coverage clusters in earnings, which accounts for 1 of those 3, with the remainder spread across 2 other categories. The tracked stories average 2 original sources each.
3 verified stories tracked
Last mentioned: Feb 25, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Allison Transmission is most often covered alongside Alcon, which appears in 3 of these 3 stories. Coverage clusters in earnings, which accounts for 1 of those 3, with the remainder spread across 2 other categories. The tracked stories average 2 original sources each. Allison Transmission appears in 3 tracked Cross-Sector stories from February 25, 2026.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Allison Transmission. Shared-story counts are live from our verified record — not editorial picks.
Allison Transmission reported a significant Q4 earnings miss, posting $1.18 per share against a $1.55 estimate, while Alcon narrowly missed expectations with a core EPS of $0.78. These results highlight a divergence in sectoral resilience, with heavy-duty industrials facing sharper headwinds than the healthcare and vision care markets.
Alcon reported a core EPS of $0.78 for the fourth quarter, slightly missing the FactSet consensus estimate of $0.79. The results highlight a period of consolidation for the eye care leader as it navigates the post-spinoff landscape and competitive pressures in surgical and vision care.
Alcon reported a Q4 core EPS of $0.78, narrowly missing the FactSet consensus of $0.79. While the miss was marginal, it highlights the ongoing pressure on medical device margins and the defensive posture of the healthcare sector compared to industrial peers.
Source: Marketscreener · Marketscreener
